Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 292

1.

JCL Roundtable: Gender differences in reduction of CVD in response to lipid-lowering drugs.

Brown WV, Mackey RH, Orringer CE, Pearson TA.

J Clin Lipidol. 2015 Sep-Oct;9(5):624-33. doi: 10.1016/j.jacl.2015.07.010. Epub 2015 Aug 3. Review.

PMID:
26350807
2.

Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010.

Record NB, Onion DK, Prior RE, Dixon DC, Record SS, Fowler FL, Cayer GR, Amos CI, Pearson TA.

JAMA. 2015 Jan 13;313(2):147-55. doi: 10.1001/jama.2014.16969. Erratum in: JAMA. 2015 Jun 2;313(21):2185.

3.

Monthly haemostatic factor variability in women and men.

Hill AM, Stewart PW, Fung MK, Kris-Etherton PM, Ginsberg HN, Tracy RP, Pearson TA, Lefevre M, Reed RG, Elmer PJ, Holleran S, Ershow AG; Dietary Effects on Lipoproteins and Thrombogenic Activity Investigators.

Eur J Clin Invest. 2014;44(3):309-18. doi: 10.1111/eci.12235.

4.

Identifying emerging research collaborations and networks: method development.

Dozier AM, Martina CA, O'Dell NL, Fogg TT, Lurie SJ, Rubinstein EP, Pearson TA.

Eval Health Prof. 2014 Mar;37(1):19-32. doi: 10.1177/0163278713501693. Epub 2013 Sep 8.

5.

American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers.

Pearson TA, Palaniappan LP, Artinian NT, Carnethon MR, Criqui MH, Daniels SR, Fonarow GC, Fortmann SP, Franklin BA, Galloway JM, Goff DC Jr, Heath GW, Frank AT, Kris-Etherton PM, Labarthe DR, Murabito JM, Sacco RL, Sasson C, Turner MB; American Heart Association Council on Epidemiology and Prevention.

Circulation. 2013 Apr 23;127(16):1730-53. doi: 10.1161/CIR.0b013e31828f8a94. Epub 2013 Mar 21. No abstract available.

6.

Commentary: What are the benefits of training deaf and hard-of-hearing doctors?

McKee MM, Smith S, Barnett S, Pearson TA.

Acad Med. 2013 Feb;88(2):158-61. doi: 10.1097/ACM.0b013e31827c0aef.

7.

Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group's report on optimizing the IRB process.

Mascette AM, Bernard GR, Dimichele D, Goldner JA, Harrington R, Harris PA, Leeds HS, Pearson TA, Ramsey B, Wagner TH.

Acad Med. 2012 Dec;87(12):1710-4. doi: 10.1097/ACM.0b013e3182720859.

8.

An epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007.

Block RC, Dozier AM, Hazel-Fernandez L, Guido JJ, Pearson TA.

Prev Chronic Dis. 2012;9:E90. Epub 2012 Apr 19.

9.

Carotid endarterectomy and carotid artery stenting utilization trends over time.

Skerritt MR, Block RC, Pearson TA, Young KC.

BMC Neurol. 2012 Mar 29;12:17. doi: 10.1186/1471-2377-12-17. Review.

10.

Public policy approaches to the prevention of heart disease and stroke.

Pearson TA.

Circulation. 2011 Dec 6;124(23):2560-71. doi: 10.1161/CIRCULATIONAHA.110.968743. No abstract available.

11.

Community participatory research with deaf sign language users to identify health inequities.

Barnett S, Klein JD, Pollard RQ Jr, Samar V, Schlehofer D, Starr M, Sutter E, Yang H, Pearson TA.

Am J Public Health. 2011 Dec;101(12):2235-8. doi: 10.2105/AJPH.2011.300247. Epub 2011 Oct 20.

12.

The quality of lifestyle and the quality of life.

Moreno M, Pearson TA.

Arch Intern Med. 2011 Nov 14;171(20):1819-20. doi: 10.1001/archinternmed.2011.442. Epub 2011 Sep 12. No abstract available.

13.

Knowledge, perception, and behaviors of relatives of people with premature heart disease: a systematic literature review.

Ton TG, Fogg TT, Fong CT, John C, Li SX, Marshall JA, Peters K, Neal W, Pearson TA.

Circulation. 2011 Aug 23;124(8):958-64. doi: 10.1161/CIRCULATIONAHA.110.940593. Review. No abstract available.

14.

Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.

Enkhmaa B, Anuurad E, Ozturk Z, Zhang W, Pearson TA, Berglund L.

Transl Res. 2011 Aug;158(2):92-8. doi: 10.1016/j.trsl.2011.01.004. Epub 2011 Feb 5.

15.

Age as a modulator of inflammatory cardiovascular risk factors.

Anuurad E, Enkhmaa B, Gungor Z, Zhang W, Tracy RP, Pearson TA, Kim K, Berglund L.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2151-6. doi: 10.1161/ATVBAHA.111.232348. Epub 2011 Jun 23.

16.

Impact of communication on preventive services among deaf American Sign Language users.

McKee MM, Barnett SL, Block RC, Pearson TA.

Am J Prev Med. 2011 Jul;41(1):75-9. doi: 10.1016/j.amepre.2011.03.004.

17.

Deaf sign language users, health inequities, and public health: opportunity for social justice.

Barnett S, McKee M, Smith SR, Pearson TA.

Prev Chronic Dis. 2011 Mar;8(2):A45. Epub 2011 Feb 15. No abstract available.

18.

The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.

Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV.

Circulation. 2011 Mar 15;123(10):1138-43. doi: 10.1161/CIR.0b013e31820d0793. Epub 2011 Jan 13. No abstract available.

19.

Building capacity across the spectrum of research translation: centers of excellence within the Rochester Clinical and Translational Science Institute.

Pearson TA, Fogg TT, Bennett N, Kieburtz K, Kitzman H, Moxley R, Puzas E.

Clin Transl Sci. 2010 Dec;3(6):272-4. No abstract available.

20.

Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer?

Geba D, Pearson TA.

Am J Prev Med. 2011 Jan;40(1):101-3. doi: 10.1016/j.amepre.2010.10.011. No abstract available.

PMID:
21146774
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk